Anthony P. Conley

3.6k total citations
119 papers, 1.9k citations indexed

About

Anthony P. Conley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Anthony P. Conley has authored 119 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 48 papers in Oncology and 26 papers in Rheumatology. Recurrent topics in Anthony P. Conley's work include Sarcoma Diagnosis and Treatment (71 papers), CAR-T cell therapy research (24 papers) and Bone Tumor Diagnosis and Treatments (20 papers). Anthony P. Conley is often cited by papers focused on Sarcoma Diagnosis and Treatment (71 papers), CAR-T cell therapy research (24 papers) and Bone Tumor Diagnosis and Treatments (20 papers). Anthony P. Conley collaborates with scholars based in United States, Spain and Italy. Anthony P. Conley's co-authors include Wei‐Lien Wang, Shreyaskumar Patel, Vinod Ravi, Alexander J. Lazar, Damon R. Reed, Vivek Subbiah, Michael J. Nathenson, Neeta Somaiah, Robert S. Benjamin and Jason Roszik and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anthony P. Conley

113 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony P. Conley United States 26 1.0k 774 379 320 273 119 1.9k
Breelyn A. Wilky United States 22 977 0.9× 912 1.2× 328 0.9× 379 1.2× 243 0.9× 101 1.7k
Maria Cristina Montesco Italy 24 596 0.6× 932 1.2× 231 0.6× 280 0.9× 170 0.6× 64 1.7k
Iwona Ługowska Poland 21 740 0.7× 1.0k 1.3× 170 0.4× 361 1.1× 211 0.8× 116 1.8k
Peter C. de Bruin Netherlands 25 765 0.7× 546 0.7× 209 0.6× 261 0.8× 266 1.0× 51 2.2k
W. Ruka Poland 25 1.4k 1.3× 1.4k 1.9× 322 0.8× 440 1.4× 287 1.1× 58 2.6k
Yumi Oshiro Japan 24 875 0.8× 482 0.6× 456 1.2× 303 0.9× 108 0.4× 80 1.8k
Javier Martínez‐Trufero Spain 20 1.1k 1.1× 976 1.3× 168 0.4× 199 0.6× 72 0.3× 124 2.0k
Agnès Neuville France 27 1.2k 1.2× 704 0.9× 471 1.2× 429 1.3× 47 0.2× 56 2.0k
Paola Casieri Italy 19 497 0.5× 624 0.8× 160 0.4× 389 1.2× 71 0.3× 43 1.5k
Kunihiko Seki Japan 27 1.1k 1.0× 465 0.6× 608 1.6× 224 0.7× 50 0.2× 73 1.8k

Countries citing papers authored by Anthony P. Conley

Since Specialization
Citations

This map shows the geographic impact of Anthony P. Conley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony P. Conley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony P. Conley more than expected).

Fields of papers citing papers by Anthony P. Conley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony P. Conley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony P. Conley. The network helps show where Anthony P. Conley may publish in the future.

Co-authorship network of co-authors of Anthony P. Conley

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony P. Conley. A scholar is included among the top collaborators of Anthony P. Conley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony P. Conley. Anthony P. Conley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tap, William D., Gregory M. Coté, Howard A. Burris, et al.. (2025). Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma. Clinical Cancer Research. 31(11). 2108–2114. 1 indexed citations
2.
Banu, Matei A., et al.. (2024). The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol. Neurosurgical FOCUS. 56(5). E15–E15. 2 indexed citations
3.
Yevich, Steven, J. Kuban, Alda L. Tam, et al.. (2024). Safety and Efficacy of Percutaneous Cryoablation for Recurrent or Metastatic Soft-Tissue Sarcoma in Adult Patients. American Journal of Roentgenology. 223(4). e2431490–e2431490. 5 indexed citations
4.
Chiang, Yi‐Ju, Anthony P. Conley, Dejka M. Araujo, et al.. (2024). Systemic therapy in NF-1 associated malignant peripheral nerve sheath tumors (MPNST).. Journal of Clinical Oncology. 42(16_suppl). 11583–11583. 1 indexed citations
5.
Denu, Ryan A., Ahsan Farooqi, Davis R. Ingram, et al.. (2024). Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.. Journal of Clinical Oncology. 42(16_suppl). 11511–11511. 2 indexed citations
6.
Yevich, Steven, J. Kuban, Alda L. Tam, et al.. (2024). Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver. Cancer. 130(15). 2703–2712. 5 indexed citations
7.
Denu, Ryan A., Justin T. Moyers, Mohamed A. Gouda, et al.. (2023). The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications. Clinical Cancer Research. 29(22). 4669–4678. 4 indexed citations
8.
Subbiah, Vivek, Sant P. Chawla, Anthony P. Conley, et al.. (2023). Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma. Clinical Cancer Research. 29(16). 2988–3003. 28 indexed citations
9.
Salkeni, Mohamad A., Brian Ko, Brian A. Van Tine, et al.. (2023). A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma.. Journal of Clinical Oncology. 41(16_suppl). 11533–11533. 1 indexed citations
10.
Boyce-Fappiano, David, Ahsan Farooqi, Devarati Mitra, et al.. (2022). Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions. Advances in Radiation Oncology. 7(3). 100913–100913. 18 indexed citations
11.
Alvarez‐Breckenridge, Christopher, Kadir C. Akdemir, Anthony P. Conley, et al.. (2022). Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels. Frontiers in Oncology. 12. 997506–997506. 5 indexed citations
12.
Flint, James H., Anthony P. Conley, M. Laura Rubin, et al.. (2020). Clear Cell Chondrosarcoma: Clinical Characteristics and Outcomes in 15 Patients. Sarcoma. 2020. 1–6. 3 indexed citations
13.
Conley, Anthony P., George D. Demetri, Robert C. Doebele, et al.. (2020). 539P Patient-reported outcomes (PROs) from patients (Pts) with NTRK fusion-positive (NTRK-fp) solid tumours receiving entrectinib in the global phase II STARTRK-2 study. Annals of Oncology. 31. S471–S472. 2 indexed citations
14.
Subbiah, Vivek, Ravi Murthy, David S. Hong, et al.. (2018). Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers. Clinical Cancer Research. 24(16). 3845–3856. 29 indexed citations
15.
Schvartsman, Gustavo, Michael J. Wagner, Behrang Amini, et al.. (2017). Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Scientific Reports. 7(1). 9519–9519. 17 indexed citations
16.
Livingston, J. Andrew, Diogo Diniz Gomes Bugano, Andrea Barbo, et al.. (2017). Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Scientific Reports. 7(1). 11836–11836. 58 indexed citations
17.
Nathenson, Michael J., Anthony P. Conley, & Edward A. Sausville. (2017). Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas. The Oncologist. 23(1). 71–83. 41 indexed citations
18.
Reynoso, David, Laura K. Nolden, Dan Yang, et al.. (2010). Synergistic induction of apoptosis by the Bcl‐2 inhibitor ABT‐737 and imatinib mesylate in gastrointestinal stromal tumor cells. Molecular Oncology. 5(1). 93–104. 23 indexed citations
19.
Wang, Wei‐Lien, Anthony P. Conley, David Reynoso, et al.. (2010). Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor. Cancer Chemotherapy and Pharmacology. 67(S1). 15–24. 62 indexed citations
20.
Conley, Anthony P., William Stevenson, & Guillermo Garcia‐Manero. (2008). Review of the Response Criteria for Myelodysplastic Syndrome. European Oncology & Haematology. 4(1). 54–54.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Breelyn A. Wilky Breakdown of academic impact, for papers by Maria Cristina Montesco Breakdown of academic impact, for papers by Iwona Ługowska Breakdown of academic impact, for papers by Peter C. de Bruin Breakdown of academic impact, for papers by W. Ruka Breakdown of academic impact, for papers by Yumi Oshiro Breakdown of academic impact, for papers by Javier Martínez‐Trufero Breakdown of academic impact, for papers by Agnès Neuville Breakdown of academic impact, for papers by Paola Casieri Breakdown of academic impact, for papers by Kunihiko Seki
Rankless by CCL
2026